Neurovance’s Phase 2b trial of the non-stimulant drug centanafadine SR has met both the primary and secondary endpoints. The research will move into Phase 3 trials in early 2017. http://www.medicalnewstoday.com/releases/311974.php...
read moreAbstract: This study tested the efficacy of a one-on-one cognitive training program (ThinkRx) and a digital training program in laboratory and school settings. In a randomized controlled study, 225 high school students were randomly assigned to one of three...
read moreThe new federal guidelines classifying ADHD as a specific disability make clear that school districts should evaluate students who may have the disorder even if they show high academic performance. Parents are entitled to ask that a district evaluate...
read moreA new study found that athletes who feel they have recovered from a concussion may still experience long-term brain changes....
read moreAbstract: The purpose of this study was to investigate the effectiveness of the ThinkRx cognitive training program. Sixty-one children (ages 6–18) were given pretest and post-test assessments using seven batteries from the Woodcock-Johnson III Tests of Cognitive Abilities and Tests of...
read moreA survey of parents of 226 school-age children who had been previously identified as having oppositional behavior and academic difficulties, found that many reported significant improvements in behavior and academics following LearningRx (www.LearningRx.com) personal brain training. The results have...
read moreThe results of a randomized controlled trial (RCT), published recently in the journal Applied Cognitive Psychology, support the efficacy of the ThinkRx® one-on-one cognitive training program in improving cognitive skills and IQ scores in students ages 8 to 14...
read moreDesigned by Elegant Themes | Powered by WordPress
Copyright © 2024 LearningRx, Inc. All rights reserved.
Use of this site is subject to our privacy policy